The number of seniors in the U.S. is expected to double by the year 2030. Currently, the elderly account for 12.7% of the U.S. population, but consume 34% of the total prescriptions-and these numbers are sure to increase enormously over the next few decades. Pharmacists will be greatly affected by this rapidly expanding geriatric population, and they will certainly be called on to offer much-needed expertise. This new textbook, Geriatric Pharmacotherapy, provides thorough coverage on therapeutic and social issues affecting elderly patients. The book is divided into two sections; the first section addresses general concepts about aging and the second section is organized by both organ system and disease states common in the elderly. These chapters contain a short summary of treatment in normal adults, and then focus on an evidence-based review of treatment in elderly patients.